The global stereotactiguided biopsy instrument market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The needlbased biopsy instruments segment is expected to account for the largest share of the market in terms of revenue, followed by localization wires and procedure trays. Breast biopsy is expected to be the fastest-growing application segment in terms of revenue, followed by lung biopsy and colorectal biopsy. North America is expected to account for the largest share of the global stereotactiguided biopsy instrument market in terms of revenue, followed by Europe and Asia Pacific.
The needlbased biopsy instruments segment accounted for a larger share than localization wires and procedure trays due to their higher accuracy rates as compared with other types of devices such as localization wires or procedure trays which are used only when there are no other options available. Breast cancer was one such example where needle-based devices were used more often than other types because they were more accurate in detecting breast cancer cells that could not be detected using mammography or ultrasound imaging techniques alone.
- Increasing prevalence of cancer.
- Increasing number of cancer patients.
- Rising demand for minimally invasive procedures.
- Growing awareness about the benefits of stereotactic-guided biopsy instrument.
- Technological advancements in the field.
Industry Growth Insights published a new data on “Stereotactic-guided Biopsy Instrument Market”. The research report is titled “Stereotactic-guided Biopsy Instrument Market research by Types (Needle-based Biopsy Instruments, Localization Wires, Procedure Trays, Others), By Applications (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others), By Players/Companies C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), Medtronic plc (Ireland)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stereotactic-guided Biopsy Instrument Market Research Report
By Type
Needle-based Biopsy Instruments, Localization Wires, Procedure Trays, Others
By Application
Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others
By Companies
C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), Medtronic plc (Ireland)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Stereotactic-guided Biopsy Instrument Market Report Segments:
The global Stereotactic-guided Biopsy Instrument market is segmented on the basis of:
Types
Needle-based Biopsy Instruments, Localization Wires, Procedure Trays, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- C. R. Bard, Inc. (U.S.)
- Becton, Dickinson and Company (U.S.)
- Cook Group Incorporated (U.S.)
- Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
- Argon Medical Devices (U.S.)
- B. Braun Melsungen AG (Germany)
- Cardinal Health, Inc. (U.S.)
- Olympus Corporation (Japan)
- Boston Scientific Corporation (U.S.)
- FUJIFILM Holdings Corporation (Japan)
- INRAD, Inc. (U.S.)
- Medtronic plc (Ireland)
Highlights of The Stereotactic-guided Biopsy Instrument Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Needle-based Biopsy Instruments
- Localization Wires
- Procedure Trays
- Others
- By Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stereotactic-guided Biopsy Instrument Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A stereotactic-guided biopsy instrument is a medical device that uses a series of X-rays to guide the placement of a needle into an area suspected of containing cancer.
Some of the major companies in the stereotactic-guided biopsy instrument market are C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), Medtronic plc (Ireland).
The stereotactic-guided biopsy instrument market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Stereotactic-guided Biopsy Instrument Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Stereotactic-guided Biopsy Instrument Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Stereotactic-guided Biopsy Instrument Market - Supply Chain
4.5. Global Stereotactic-guided Biopsy Instrument Market Forecast
4.5.1. Stereotactic-guided Biopsy Instrument Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Stereotactic-guided Biopsy Instrument Market Size (000 Units) and Y-o-Y Growth
4.5.3. Stereotactic-guided Biopsy Instrument Market Absolute $ Opportunity
5. Global Stereotactic-guided Biopsy Instrument Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Type
5.3.1. Needle-based Biopsy Instruments
5.3.2. Localization Wires
5.3.3. Procedure Trays
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Stereotactic-guided Biopsy Instrument Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Application
6.3.1. Breast Biopsy
6.3.2. Lung Biopsy
6.3.3. Colorectal Biopsy
6.3.4. Prostate Biopsy
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Stereotactic-guided Biopsy Instrument Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Stereotactic-guided Biopsy Instrument Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Stereotactic-guided Biopsy Instrument Demand Share Forecast, 2019-2026
9. North America Stereotactic-guided Biopsy Instrument Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Application
9.4.1. Breast Biopsy
9.4.2. Lung Biopsy
9.4.3. Colorectal Biopsy
9.4.4. Prostate Biopsy
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Type
9.7.1. Needle-based Biopsy Instruments
9.7.2. Localization Wires
9.7.3. Procedure Trays
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Stereotactic-guided Biopsy Instrument Demand Share Forecast, 2019-2026
10. Latin America Stereotactic-guided Biopsy Instrument Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Application
10.4.1. Breast Biopsy
10.4.2. Lung Biopsy
10.4.3. Colorectal Biopsy
10.4.4. Prostate Biopsy
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Type
10.7.1. Needle-based Biopsy Instruments
10.7.2. Localization Wires
10.7.3. Procedure Trays
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Stereotactic-guided Biopsy Instrument Demand Share Forecast, 2019-2026
11. Europe Stereotactic-guided Biopsy Instrument Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Application
11.4.1. Breast Biopsy
11.4.2. Lung Biopsy
11.4.3. Colorectal Biopsy
11.4.4. Prostate Biopsy
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Type
11.7.1. Needle-based Biopsy Instruments
11.7.2. Localization Wires
11.7.. Procedure Trays
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Stereotactic-guided Biopsy Instrument Demand Share, 2019-2026
12. Asia Pacific Stereotactic-guided Biopsy Instrument Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Application
12.4.1. Breast Biopsy
12.4.2. Lung Biopsy
12.4.3. Colorectal Biopsy
12.4.4. Prostate Biopsy
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Type
12.7.1. Needle-based Biopsy Instruments
12.7.2. Localization Wires
12.7.3. Procedure Trays
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Stereotactic-guided Biopsy Instrument Demand Share, 2019-2026
13. Middle East & Africa Stereotactic-guided Biopsy Instrument Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Application
13.4.1. Breast Biopsy
13.4.2. Lung Biopsy
13.4.3. Colorectal Biopsy
13.4.4. Prostate Biopsy
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Stereotactic-guided Biopsy Instrument Market Size and Volume Forecast by Type
13.7.1. Needle-based Biopsy Instruments
13.7.2. Localization Wires
13.7.3. Procedure Trays
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Stereotactic-guided Biopsy Instrument Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Stereotactic-guided Biopsy Instrument Market: Market Share Analysis
14.2. Stereotactic-guided Biopsy Instrument Distributors and Customers
14.3. Stereotactic-guided Biopsy Instrument Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. C. R. Bard, Inc. (U.S.)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Becton, Dickinson and Company (U.S.)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cook Group Incorporated (U.S.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Argon Medical Devices (U.S.)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. B. Braun Melsungen AG (Germany)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cardinal Health, Inc. (U.S.)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Olympus Corporation (Japan)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Boston Scientific Corporation (U.S.)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. FUJIFILM Holdings Corporation (Japan)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. INRAD, Inc. (U.S.)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Medtronic plc (Ireland)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
